|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 28, 2017 ) According to Publisher, the Global Glucose Biosensor Market is accounted for $15.3 billion in 2015 and is expected to reach $30.5 billion by 2022 growing at a CAGR of 10.29% from 2015 to 2022. Growing demand for expansion of technologically advanced products and non-invasive products are some of the primary factors favouring the market growth. Furthermore, increasing frequency of diabetes across the globe, need for early diabetes detection and patient awareness levels are some of the drivers fuelling the market growth. However, high cost, reluctance towards the adoption of the new treatment practices and slow rate of commercialization are the restraints limiting the market growth. The recent trends in Glucose Biosensors market are increasing adoption of the POC diagnostic kits and wearable healthcare devices.
Fluorescence segment is expected to capture the largest market share over the forecast period. North America is expected to witness highest growth rate in terms of value and share. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S. is attributing to the favorable North American market.
For more information @ http://www.reportsweb.com/glucose-biosensor-global-market-outlook-2015-2022
Some of the key players in the market include Roche Diagnostics, LifeScan Inc., Abbott Laboratories, Bayer, Medtronic Inc., Pinnacle Medical Solutions Inc., AgaMatrix Inc., Sanofi S.A., BioSense Medical Devices, LLC, Nova Biomedical, Lifesensors, Inc., Animas Corporation, Siemens Healthcare Diagnostics, Inc., F. Hoffman-La Roche and M-Biotech Limited.
End User Covered:
- Hospitals
- Homecare Diagnostics
- Other end users
Type Covered:
- Amprometric Glucose Biosensors
- Fluorescence Glucose Biosensors
- Other types
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216389/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216389/buying
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Glucose Biosensor Market, By End User
6 Global Glucose Biosensor Market, By Type
7 Global Glucose Biosensor Market, By Geography
8 Key Developments
9 Company Profiling
9.1 Roche Diagnostics
9.2 LifeScan Inc.
9.3 Abbott Laboratories
9.4 Bayer
9.5 Medtronic Inc.
9.6 Pinnacle Medical Solutions Inc.
9.7 AgaMatrix Inc.
9.9 Sanofi S.A.
9.9 BioSense Medical Devices, LLC
9.10 Nova Biomedical
9.11 Lifesensors, Inc.
9.12 Animas Corporation
9.13 Siemens Healthcare Diagnostics, Inc.
9.14 F. Hoffman-La Roche
9.15 M-Biotech Limited
Purchase Report at http://www.reportsweb.com/buy&RW0001216389/buy/4150 .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
